首页> 外国专利> COMPOSITION, METHODS FOR PRODUCING AND APPLICATION OF A FRAME BASED ON A FIBRONECTIN TYPE III DOMAIN

COMPOSITION, METHODS FOR PRODUCING AND APPLICATION OF A FRAME BASED ON A FIBRONECTIN TYPE III DOMAIN

机译:基于纤维结合蛋白III型结构域的骨架的组成,制备方法和应用

摘要

1. An isolated protein framework based on the type III fibronectin domain (FN3), comprising an amino acid sequence derived from the consensus sequence of the FN3 domain, wherein the amino acid sequence is at least 75% identical to the consensus sequence of the FN3.2 domain. An isolated protein framework based on the type III fibronectin domain (FN3) containing the amino acid sequence derived from the consensus sequence of the FN3 domain, wherein the amino acid sequence is at least 75% identical to SEQ ID NO: 16.3. The protein framework according to claim 2, containing 7 strands and 6 loops between them. The protein framework according to claim 3, containing the amino acid sequence of SEQ ID NO: 16 and forming loops in the region of residues 13-16, 22-28, 38-43, 51-54, 60-64 and 75-81 of the sequence SEQ ID NO: 16 capable of binding to cellular proteins and / or nucleic acid molecules. 5. The protein framework according to claim 3, containing the amino acid sequence of SEQ ID NO: 16 and forming loops in the region of residues 13-16, 22-28, 38-43, 51-54, 60-64 and 75-81 of the sequence SEQ ID NO: 16 capable of binding to cellular proteins and / or nucleic acid molecules, wherein one or more loops are altered to bind to a target. The protein framework according to any one of claims 1 to 5, wherein said framework connects the target with at least one of affinity values selected from at least 10M, at least 10M, at least 10M, and at least 10M, at least 10M, at least 10M and at least 10M, determined by surface plasmon resonance or kinetic exclusion analysis (Kinexa). 7. The protein framework according to any one of claims 1 to 5, where
机译:1.基于III型纤连蛋白结构域(FN3)的分离的蛋白质框架,其包含衍生自FN3结构域的共有序列的氨基酸序列,其中所述氨基酸序列与FN3的共有序列至少75%相同。 .2域。基于III型纤连蛋白结构域(FN3)的分离的蛋白质框架,其包含衍生自FN3结构域的共有序列的氨基酸序列,其中该氨基酸序列与SEQ ID NO:16.3至少75%相同。 3.根据权利要求2所述的蛋白质框架,其包含7条链和它们之间的6个环。 4.根据权利要求3所述的蛋白质框架,其包含SEQ ID NO:16的氨基酸序列,并且在残基13-16、22-28、38-43、51-54、60-64和75-81的区域中形成环。 SEQ ID NO:16的序列能够结合细胞蛋白和/或核酸分子。 5.根据权利要求3的蛋白质框架,其包含SEQ ID NO:16的氨基酸序列,并且在残基13-16、22-28、38-43、51-54、60-64和75的区域中形成环。能够结合细胞蛋白和/或核酸分子的序列SEQ ID NO:16的-81,其中一个或多个环被改变以结合靶标。 6.根据权利要求1至5中任一项所述的蛋白质构架,其中所述构架将所述靶与选自以下的至少一种亲和力值连接:至少10M,至少10M,至少10M和至少10M,至少10M。通过表面等离子体共振或动力学排斥分析(Kinexa)确定至少10M和至少10M。 7.根据权利要求1-5中任一项的蛋白质框架,其中

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号